Many expectant parents don’t know that the Quad Screen test is a common prenatal screening used to assess the risk of certain genetic conditions in the fetus. It measures specific markers in your blood and gives your doctor useful information about your pregnancy. Understanding this test matters, especially when it comes to reading results and deciding what to do next. What exactly does the Quad Screen involve, and how might it affect your pregnancy?
Quick Answer
- The Quad Screen is a blood test done between weeks 15 and 22 of pregnancy.
- It measures four markers (AFP, hCG, estriol, and inhibin A) to estimate the risk of Down syndrome, trisomy 18, and open neural tube defects like spina bifida.
- A positive result does not confirm a diagnosis. It means further testing may be recommended.
- Talk with your healthcare provider to understand your results and plan next steps.
What Is the Quad Screen Test?
The Quad Screen Test, also called the quad marker screen, is a blood test done during the second trimester of pregnancy to assess the risk of certain genetic conditions in the developing fetus.
This screening analyzes four specific markers in your blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), estriol, and inhibin A.
The Quad Screen does not diagnose conditions. It estimates the likelihood of abnormalities such as Down syndrome, trisomy 18, or open neural tube defects like spina bifida. Your healthcare provider can help you decide whether this test makes sense based on your medical history and risk factors. For a broader overview of prenatal genetic screening options, ACOG’s patient FAQ on prenatal genetic screening is a helpful resource.
What Does the Quad Screen Measure?
The Quad Screen measures specific hormone levels in your blood to assess potential risks during pregnancy.
It screens for neural tube defects and detects certain chromosomal abnormalities, such as Down syndrome and trisomy 18.
Knowing what these measurements mean can help you make informed decisions about your pregnancy care.
Hormone Levels Assessment
The Quad Screen checks four key hormone levels in your blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), estriol, and inhibin A.
Each hormone provides useful information about your pregnancy’s health. Elevated AFP levels may point to a higher risk for certain conditions, while abnormal hCG and estriol levels can suggest chromosomal abnormalities like Down syndrome or trisomy 18. Inhibin A levels help fine-tune the risk assessment further.
Neural Tube Defects
The Quad Screen can also signal the risk of neural tube defects (NTDs). The test evaluates four markers: AFP, hCG, estriol, and inhibin A.
Elevated AFP levels may indicate a higher risk of NTDs, which include conditions such as spina bifida and anencephaly. The test is performed between 15 and 22 weeks of pregnancy, allowing for early detection and possible follow-up.
A positive result does not confirm a defect. It simply means further testing is worth considering. Your healthcare provider can help you interpret the results and figure out what to do next.
Chromosomal Abnormalities Detection
Beyond neural tube defect screening, the Quad Screen also assesses the likelihood of certain chromosomal abnormalities, including Down syndrome and trisomy 18.
The test measures specific proteins and hormones, including AFP, hCG, estriol, and inhibin A. By reviewing these levels, healthcare providers can estimate the risk of these chromosomal conditions in your developing fetus.
A positive result does not confirm a diagnosis, but it can lead to further testing, such as amniocentesis or chorionic villus sampling (CVS). Understanding these results helps you make informed decisions about your pregnancy and any necessary follow-up care.
When Is the Quad Screen Performed?
The Quad Screen is typically done between the 15th and 22nd weeks of pregnancy, making it a routine part of prenatal care in many settings.
If you are still in your first trimester, your provider may talk with you about the timing of this screening or whether alternatives like first-trimester combined screening or cell-free DNA (cfDNA/NIPT) testing are a better fit.
First Trimester Timing
The quad screen is a second-trimester test, performed between the 15th and 22nd weeks of pregnancy. In the first trimester, your provider may begin planning for this test or discuss other screening options with you.
This window matters because it’s when the test most accurately assesses certain genetic conditions and developmental concerns. Performing it too early or too late can produce less reliable results, which may affect your healthcare decisions. Your provider will guide the timing based on your situation and any risk factors you have.
Routine Screening Schedule
The quad screen is scheduled between the 15th and 22nd weeks of pregnancy.
Staying within this window is key. The test measures specific markers that can indicate potential birth defects, and testing outside this range can affect accuracy.
Your healthcare provider will help you schedule based on your individual circumstances. The quad screen is non-invasive and can provide valuable information, with further testing available if the results call for it.
How Is the Quad Screen Conducted?
A healthcare professional draws a blood sample from you during the 15th to 22nd weeks of pregnancy.
The process is straightforward. A small amount of blood is collected from your arm using a needle, and it only takes a few minutes.
The sample then goes to a laboratory for analysis. The lab measures four specific markers: AFP, hCG, estriol, and inhibin A. These markers help evaluate the risk of certain chromosomal conditions in your baby, such as Down syndrome and spina bifida.
You will typically receive your results within about 2 to 7 business days, giving you time to follow up with your provider if needed.
What Do the Results Mean?
Quad screen results measure specific substances in your blood to assess the risk of certain conditions, like Down syndrome and neural tube defects. Results are usually labeled as screen negative (lower risk) or screen positive (higher risk) and include a numerical risk estimate.
Go over your results with your healthcare provider. They can help you interpret them accurately and explain what the findings mean for your pregnancy.
What Happens if the Results Are Abnormal?
Abnormal quad screen results mean your healthcare provider will likely recommend additional testing to look more closely at your baby’s health. This may include an ultrasound or more targeted blood tests.
Abnormal results do not guarantee a problem. They signal that further evaluation is worthwhile. Your doctor can walk you through the implications and what they mean for your specific situation.
Your emotional well-being matters during this process. Consider reaching out to counselors or support groups for extra support as you navigate next steps.
Staying informed and involved in your care gives you a strong foundation for making decisions.
Frequently Asked Questions
Is the Quad Screen Test Safe for My Baby?
Yes, the quad screen test is safe for your baby. It is a non-invasive blood test that assesses the risk of certain conditions without posing any physical risk to you or your developing child.
Can I Refuse the Quad Screen Test?
Yes, you can decline the quad screen test. Talk with your healthcare provider about your concerns. They can help you understand what opting out might mean and discuss any alternative screening options available to you.
How Much Does the Quad Screen Cost?
Costs vary widely by location, laboratory, and insurance. A national independent lab lists a self-pay price of about $199 for a quad screen, while some hospital list charges can exceed $500. Use your lab’s price estimator and reference CPT 81511 (or component codes 82105, 82677, 84702, and 86336) to get an estimate for your situation.
Will My Insurance Cover the Quad Screen Test?
Coverage depends on your plan. Check with your insurance provider to understand your benefits, including any out-of-pocket costs you might face during the testing process.
Are There Alternatives to the Quad Screen Test?
Yes. Options include non-invasive prenatal testing (NIPT/cfDNA), typically available from 10 weeks, and the first-trimester combined screen, which pairs blood tests with a nuchal translucency (NT) ultrasound. Talk with your healthcare provider to find the best option for your situation.
Conclusion
The Quad Screen test is a practical tool for expectant parents, acting like a compass through the often unfamiliar terrain of prenatal care. Understanding its purpose, timing, and what results mean keeps you prepared for whatever comes next. If results raise questions, treat them as a starting point for gathering more information rather than a final verdict. Knowledge puts you in a stronger position to make informed decisions for you and your baby’s future.
